Day: July 15, 2020
GRAND HAVEN, Mich., July 15, 2020 (GLOBE NEWSWIRE) — Access-Power & Co, Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce that we have begun taking payments online and over the telephone for our revolutionary new curbside home delivery service of Medical Marijuana Clones and Medical Hemp Clones. Our business model is a non-THC delivery of baby little live plants. This is a new trademarked and patent pending service with the US Patent and Trademark Service or http://www.uspto.gov.Our mark publication is found here: https://teas.uspto.gov/submit250/xslt.service?nozip=yes&stamp=USPTO/BAS-2600:1700:d590:6e60:90e9:1330:c123:2efd-20200715113827035902-New/Application-740bc54d78d89b5547b8e1b124b161124d226bd7677d83ed3012b25e7e83bb41&obj=mark.jpgOur new website to generate...
XBiotech annonce avoir découvert que le blocage de l’interleukine-1a réduit les lésions cérébrales et le déficit neurologique à la suite d’un accident vasculaire cérébral
Written by Customer Service on . Posted in Public Companies.
AUSTIN, Texas, 15 juill. 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui la publication de ses résultats dans la prestigieuse revue Circulation éditée par l’American Heart Association. L’article intitulé « Post-Ischemic Administration of IL-1a Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke » (L’administration post-ischiémique d’anticorps neutralisant l’IL-1a réduit les dommages cérébraux et le déficit neurologique lors d’accidents vasculaires expérimentaux) indique une utilisation possible de l’anticorps médicamenteux candidat de XBiotech qui bloque l’interleukine-1 alpha (IL-1⍺) dans le cadre d’une thérapeutique visant à réduire les dommages cérébraux et le déficit neurologique après un accident vasculaire....
XBiotech gibt Forschungsergebnis bekannt: die Blockade von Interleukin-1a verringert Hirnschädigungen und neurologische Defizite nach Schlaganfall
Written by Customer Service on . Posted in Public Companies.
AUSTIN, Texas, July 15, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) hat heute Forschungsergebnisse bekanntgegeben, die in der renommierten Zeitschrift Circulation der American Heart Association veröffentlicht wurden. Die Publikation mit dem Titel Post-Ischemic Administration of IL-1a Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke (Postischämische Verabreichung von IL-1a-neutralisierenden Antikörpern reduziert Hirnschäden und neurologische Defizite bei experimentellem Schlaganfall) weist daraufhin, dass der Medikamentenkandidaten-Antikörper von XBiotech, der Interleukin-1-Alpha (IL-1⍺) blockiert, als Therapeutikum zur Verringerung von Hirnschäden und neurologischen Defiziten nach einem Schlaganfall in Frage kommt. Die Forschungsarbeiten wurden von Dr. Giovanni Camici geleitet,...
Union Bankshares Announces Earnings for the three and six months ended June 30, 2020 and Declares Quarterly Dividend
Written by Customer Service on . Posted in Public Companies.
MORRISVILLE, Vt., July 15, 2020 (GLOBE NEWSWIRE) — Union Bankshares, Inc. (NASDAQ – UNB) today announced results for the three and six months ended June 30, 2020 and declared a regular quarterly cash dividend. Consolidated net income for the three months ended June 30, 2020 were $2.7 million, or $0.60 per share, compared to $2.5 million, or $0.56 per share, for the same period in 2019 and $4.9 million, or $1.09 per share, for the six months ended June 30, 2020, compared to $5.2 million, or $1.15 per share, for the same period in 2019.Second Quarter HighlightsConsolidated net income increased $138 thousand, or 5.4%, to $2.7 million for the second quarter of 2020 compared to the second quarter of 2019 due to increases in net interest income of $271 thousand and noninterest income of $517 thousand, partially offset by increases...
VERB Announces Selected Preliminary Unaudited Operating Results for Second Quarter 2020
Written by Customer Service on . Posted in Public Companies.
NEWPORT BEACH, Calif. and SALT LAKE CITY, July 15, 2020 (GLOBE NEWSWIRE) — VERB Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), a leader in interactive video-based sales enablement applications, including interactive livestream ecommerce, webinar, CRM, and marketing applications for entrepreneurs and enterprises, today announced selected preliminary unaudited operating results for the three months ended June 30, 2020.For the three months ended June 30, 2020, the Company reports preliminary Software as a Service (SaaS) recurring subscription revenue of approximately $1,264,000, up from $1,057,000 reported in first quarter 2020; total digital revenue of approximately $1,668,000, up from $1,457,000 reported in first quarter 2020; total non-digital revenue of approximately $941,000, up from...
Inventiva announces the closing of $107.7 million initial public offering on the Nasdaq Global Market
Written by Customer Service on . Posted in Public Companies.
Daix (France), July 15, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (“NASH”), mucopolysaccharidoses (“MPS”) and other diseases with significant unmet medical need, announced today the closing of its previously announced initial public offering on the Nasdaq Global Market of an aggregate of 7,478,261 new ordinary shares in the form of American Depositary Shares (“ADSs”), each representing one ordinary share, at an offering price of $14.40 per ADS (the “Offering”). Aggregate gross proceeds of the Offering, before deducting underwriting commissions and estimated expenses payable by the Company, were approximately $107.7 million (€94.9 million1). All of the...
Inventiva annonce la réalisation de son introduction en bourse sur le Nasdaq Global Market pour un montant de 107,7 millions de dollars U.S.
Written by Customer Service on . Posted in Public Companies.
Daix (France), le 15 Juillet 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (« NASH »), des mucopolysaccharidoses (« MPS ») et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui la réalisation de son introduction en bourse sur le Nasdaq Global Market précédemment annoncée pour un nombre total de 7.478.261 actions ordinaires nouvelles, sous la forme d’American Depositary Shares (« ADSs »), chacune d’entre elles représentant une action ordinaire, à un prix de $14,40 par ADS (l’ « Offre »). Le montant brut total de l’Offre, avant déduction des commissions des intermédiaires financiers et frais...
Les Hôtels Baverez : Information Trimestrielle 2e trimestre 2020
Written by Customer Service on . Posted in Public Companies.
LES HOTELS BAVEREZ S.A.2, place des Pyramides 75001 PARISCapital € 10.127.050 – Code NAF 5510 ZR.C.S. PARIS 572 158 558ISIN : FR 0007080254Mnémonique : ALLHBEURONEXT GrowthCommuniqué, Paris le 16 juillet 2020COMMUNIQUE : INFORMATION TRIMESTRIELLE – 2ième TRIMESTRE 2020Variation du Chiffre d’affaires au 30 juin 2020 : – 68,13 %L’activité de l’hôtel Regina a été ralentie par les grèves sur la réforme des retraites de fin d’année 2019 et début 2020. Depuis le 17 mars l’hôtel est totalement fermé à la vente ainsi que les espaces de restauration. Il devrait rouvrir ses portes à la clientèle en septembre.La baisse d’activité de l’hôtel Majestic résulte sur le premier trimestre de l’impact du mouvement précité comme pour l’hôtel Regina, mais également de la fermeture de sept chambres pour création de cinq nouvelles unités. En effet, l’hôtel...
HealthEquity Announces Closing of Sale of Additional Shares
Written by Customer Service on . Posted in Public Companies.
DRAPER, Utah, July 15, 2020 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”) today announced the closing of the underwritten public offering of an additional 690,000 shares of its common stock pursuant to the exercise in full by the underwriters of their over-allotment option. The gross proceeds to HealthEquity from the sale of these shares are $37,480,800. HealthEquity intends to use the net proceeds from the offering (including the $257.6 million in gross proceeds from the sale of shares earlier this week) to free up additional capital for organic and inorganic growth by pre-paying $200 million under its term loan facility, with the remaining proceeds to be used for general corporate purposes, which may include additional pre-payments under its term loan facility and/or potential acquisitions.Wells...
Flushing Bank Receives Approval for Second Round of Grant Money from Federal Home Loan Bank of New York’s (FHLBNY) Small Business Recovery Grant Program to Assist Local Small Businesses and Non-Profit Organizations
Written by Customer Service on . Posted in Public Companies.
UNIONDALE, N.Y., July 15, 2020 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq: FFIC), the parent holding company for Flushing Bank (the “Bank”), announced today that the Bank has been approved for a second round of funding from the FHLBNY Small Business Recovery Grant Program. These funds are intended to support the financial security and health of workers employed by organizations that have suffered a decrease in revenue as a result of the ongoing COVID-19 crisis. The Bank will disburse the grant money to local small businesses and non-profit organizations in their market area.John R. Buran, President and CEO, stated, “As a community bank, we recognize our responsibility to help small businesses and non-profit organizations who employ and support the individuals and families struggling in our communities....